CV Sciences CEO Joseph Dowling – Mainstreaming Cannabinoids

Cannabidiol (CBD) is one of the major cannabinoids found in cannabis. CV Sciences (OTCQB: CVSI) operates in two divisions: its Consumer Products side which focuses on CBD products for the consumer market and its Drug Development division – the first medical solution it’s working on is a nicotine cessation product using synthetic nicotine and cannabidiol. CEO Joseph Dowling on getting CBD out of the hands of the DEA; dialoguing with FDA based on science and years of data. Strong regulatory environment will grow the industry, not restrict it. Using expertise from fish oil industry.

Catch all CEO Interviews – https://bit.ly/3caWD5x

Start Your Free Trial of Seeking Alpha Premium Today – https://bit.ly/3fEhhLI

Power to Investors.

source